Silexion Therapeutics SLXN Gained 5613 Can It Break 044 20260520 Citigroup C Shows Potential as a LongTerm Value Play in Current Market Strategy STRF Stock Steady at 10041 Support at 9539 20260520 Cronos CRON Surges 172 Nearing 278 Resistance 20260520 Patrick Bruel Faces Sexual Assault Allegations Potential Impact on Brand and Entertainment Sector LuxExperience LUXE Q1 2026 Earnings Miss Sparks Concern